IMIDomics
Sergio H. Martínez-Mateu, MSc, is a Machine Learning Scientist at IMIDomics where he applies statistics and machine learning in the context of immune-mediated inflammatory diseases (IMIDs). In 2017 he joined IMIDomics and has contributed to research projects involving the management, analysis and integration of genetics, transcriptomics, epigenetics, metabolomics, proteomics and clinical data. Mr. Martínez-Mateu focuses primarily on disease subtyping and treatment response prediction using omics and multi-omics data. He received his double Bachelor’s degree in Physics and Mathematics from the Autonomous University of Barcelona, Spain, in 2017 and earned his MSc in Statistics and Operations Research at the Polytechnic University of Catalonia, Spain, in 2020.
This person is not in any offices
IMIDomics
IMIDomics, Inc. is a biotechnology company focused on the discovery and development of new medicines for the treatment of immune-mediated inflammatory diseases (IMIDs).